Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Intangibles (2017 - 2019)

Amphastar Pharmaceuticals (AMPH) has 4 years of Change in Intangibles data on record, last reported at $151000.0 in Q1 2019.

  • For Q1 2019, Change in Intangibles fell 96.57% year-over-year to $151000.0; the TTM value through Dec 2025 reached $151000.0, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
  • Change in Intangibles reached $151000.0 in Q1 2019 per AMPH's latest filing, down from $4.4 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $4.4 million in Q1 2018 and bottomed at $151000.0 in Q1 2019.
  • Average Change in Intangibles over 3 years is $1.6 million, with a median of $1.0 million recorded in 2017.
  • Peak YoY movement for Change in Intangibles: surged 340.0% in 2018, then plummeted 96.57% in 2019.
  • A 3-year view of Change in Intangibles shows it stood at $1.0 million in 2017, then skyrocketed by 340.0% to $4.4 million in 2018, then tumbled by 96.57% to $151000.0 in 2019.
  • Per Business Quant database, its latest 3 readings for Change in Intangibles were $151000.0 in Q1 2019, $4.4 million in Q1 2018, and $1.0 million in Q2 2017.